- Home
- SXI vs IRON Comparison
SXI vs IRON Comparison
Compare SXI & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXI
- IRON
- Stock Information
- Founded
- SXI 1955
- IRON 2017
- Country
- SXI United States
- IRON United States
- Employees
- SXI N/A
- IRON N/A
- Industry
- SXI Industrial Machinery/Components
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- SXI Industrials
- IRON Health Care
- Exchange
- SXI Nasdaq
- IRON Nasdaq
- Market Cap
- SXI 2.8B
- IRON 3.4B
- IPO Year
- SXI N/A
- IRON N/A
- Fundamental
- Price
- SXI $233.35
- IRON $94.37
- Analyst Decision
- SXI Strong Buy
- IRON Strong Buy
- Analyst Count
- SXI 3
- IRON 12
- Target Price
- SXI $264.00
- IRON $108.83
- AVG Volume (30 Days)
- SXI 127.2K
- IRON 439.4K
- Earning Date
- SXI 10-30-2025
- IRON 11-06-2025
- Dividend Yield
- SXI 0.58%
- IRON N/A
- EPS Growth
- SXI N/A
- IRON N/A
- EPS
- SXI 4.36
- IRON N/A
- Revenue
- SXI $837,074,000.00
- IRON N/A
- Revenue This Year
- SXI $14.61
- IRON N/A
- Revenue Next Year
- SXI $7.58
- IRON N/A
- P/E Ratio
- SXI $53.62
- IRON N/A
- Revenue Growth
- SXI 18.51
- IRON N/A
- 52 Week Low
- SXI $128.85
- IRON $30.82
- 52 Week High
- SXI $247.16
- IRON $97.12
- Technical
- Relative Strength Index (RSI)
- SXI 54.37
- IRON 70.43
- Support Level
- SXI $219.62
- IRON $87.94
- Resistance Level
- SXI $234.53
- IRON $92.66
- Average True Range (ATR)
- SXI 8.27
- IRON 4.02
- MACD
- SXI -1.27
- IRON 0.07
- Stochastic Oscillator
- SXI 69.32
- IRON 81.03
About SXI Standex International Corporation
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.